10/24/2024 / By Lance D Johnson
A groundbreaking literature review by William Parker, Ph.D., has raised significant concerns about the safety of acetaminophen — commonly known as Tylenol — when administered to children. Published in Clinical and Experimental Pediatrics, the study reveals troubling associations between basic pediatric doses of the drug and severe, potentially permanent impairments in cognition and socialization in children. These cognitive impairments may lead to various levels of autism.
Acetaminophen, widely used for fever reduction, mild to moderate pain relief, and adverse events from vaccination, has long been associated with liver toxicity. Additionally, the scientific literature also provides evidence that the drug disrupts the nervous system of children in a way that can forever change how they communicate and process the world around them.
Dr. Parker, the CEO of the nonprofit research firm WPLab, highlighted a critical oversight in previous studies on this issue. These studies focused primarily on acetaminophen use during pregnancy, while neglecting postnatal exposure — an area where he suspects the greatest risk lies.
“Less than 20% of autism spectrum disorder (ASD) cases can be attributed to maternal acetaminophen use during pregnancy. The majority of risks occur after birth,” Parker explained in an interview with the Defender.
Parker’s extensive review examines 20 lines of evidence, including animal studies and epidemiological data, specifically looking at connections between acetaminophen exposure and the rise of ASD and attention-deficit/hyperactivity disorder (ADHD). Among the main findings:
Acetaminophen, found in over 600 prescription and over-the-counter drugs, is widely used in pediatric care, without a proper understanding of its risks. Medical professionals and parents are ignoring the long-term neurological risks by using this drug frivolously at every sign of fever.
“Health professionals often find it hard to accept that one of the most commonly used drugs could be contributing to a complex behavioral issue like ASD,” Parker stated. “However, the evidence warrants a serious reevaluation of how we approach acetaminophen use in young children.”
Sources include:
ECEP.org [PDF]
Tagged Under:
Acetaminophen, autism, behavioral issues, Big Pharma, brain damaged, brain development, brain health, children's health, cognitive impairment, disease causes, Mind, mind body science, neurlogical damage, neurotoxicity, pharmaceutical fraud, real investigations, research
This article may contain statements that reflect the opinion of the author
COPYRIGHT © 2017 BIG PHARMA NEWS